AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 51 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $94,000 | +4.4% | 65,000 | -20.0% | 0.01% | 0.0% |
| Q3 2014 | $90,000 | -9.1% | 81,200 | +49.5% | 0.01% | 0.0% |
| Q2 2014 | $99,000 | +230.0% | 54,300 | +171.5% | 0.01% | +100.0% |
| Q1 2014 | $30,000 | +30.4% | 20,000 | +60.0% | 0.00% | +100.0% |
| Q4 2013 | $23,000 | -20.7% | 12,500 | -10.7% | 0.00% | -33.3% |
| Q3 2013 | $29,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |